Both in Pharmaceuticals
GT Biopharma vs Lexaria Bioscience
Over the past year GTBP returned −68.7% and LEXX returned −75.6%; their daily moves had a correlation of 0.08.
GTBP −68.7% LEXX −75.6%Growth of $1, one year, split-adjusted
| Metric | GTBP | LEXX |
|---|---|---|
| Price | $4.84 | $4.07 |
| Market cap | $8.7M | $8.6M |
| Today | −8.16% | +0.99% |
| 1 month | −24.0% | +25.6% |
| 6 months | −51.9% | −59.8% |
| Year to date | −75.3% | −56.0% |
| 1 year | −68.9% | −73.9% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 44.2× |
| Net cash | $5.0M | $3.6M |
| Dividend yield | — | — |
| Volatility (60d) | 958.4% | 195.3% |
| Short % of float | 24.1% | 16.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).